Linked infacebooktwitteryoutube
Atavistik Bio

Atavistik Bio Collaborates with Pfizer to Advance Precision Allosteric Therapeutics

EGFR-mutated NSCLC

European Commission Approves Amivantamab-Lazertinib Combination for First-Line Treatment of EGFR-Mutated NSCLC

Sangamo Therapeutics

Sangamo Therapeutics Regains Rights to Hemophilia A Gene Therapy Following Pfizer Exit

Innovent Biologics

Innovent Biologics Collaborates with Roche to Advance DLL3 ADC Candidate IBI3009

Claudin18.2

CARsgen Therapeutics Announces Positive Phase II Results for Satricabtagene Autoleucel in Gastric Cancer

IDEAYA Biosciences

IDEAYA Biosciences and Hengrui Pharma Collaborate on Novel DLL3-Targeting ADC for Precision Oncology

Novartis

Novartis Reports Positive Phase III STEER Study Results for OAV101 IT in SMA Type 2 Patients

digital pathology

Digital Pathology Biomarkers: Transforming Precision Oncology Diagnostics and Treatment

Daiichi Sankyo

DATROWAY® Approved in Japan for HR Positive, HER2 Negative Breast Cancer

PD-1 inhibitor

FDA Approves Injectable Form of Opdivo, Offering Greater Convenience for Cancer Patients

Karkinos

Reliance Acquires Oncology Platform Karkinos for ₹375 Crore

PD-L1-Positive

FDA Approves TEVIMBRA® for First-Line Treatment of PD-L1-Positive Gastric and Gastroesophageal Junction Cancers

CSIR

CSIR's 2024 Healthcare Breakthroughs: Advancing Cancer Detection, Genetic Disorders, and Neurodegenerative Disease Research

Dr. Sandip Shah

Dr. Sandip Shah Appointed Chairman of NABL: A Visionary Leader in Indian Healthcare

Global Trends

Global and Indian Genetic Testing Market Trends in 2025